###begin article-title 0
###xml 90 94 <span type="species:ncbi:10090">Mice</span>
The ER-Bound RING Finger Protein 5 (RNF5/RMA1) Causes Degenerative Myopathy in Transgenic Mice and Is Deregulated in Inclusion Body Myositis
###end article-title 0
###begin p 1
Conceived and designed the experiments: ZR AD KB YH MM GS. Performed the experiments: AD KB YH MM SJ AM BK DB MCM RM AB LG. Analyzed the data: ZR AD KB YH MM PP GS MCM. Contributed reagents/materials/analysis tools: SL ZR AD KB YH MM PP SJ CS GS MCM. Wrote the paper: ZR AD GS.
###end p 1
###begin p 2
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 202 205 <span type="species:ncbi:172644">aka</span>
###xml 413 421 <span type="species:ncbi:9606">patients</span>
###xml 788 803 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
###xml 1469 1473 <span type="species:ncbi:10090">mice</span>
Growing evidence supports the importance of ubiquitin ligases in the pathogenesis of muscular disorders, although underlying mechanisms remain largely elusive. Here we show that the expression of RNF5 (aka RMA1), an ER-anchored RING finger E3 ligase implicated in muscle organization and in recognition and processing of malfolded proteins, is elevated and mislocalized to cytoplasmic aggregates in biopsies from patients suffering from sporadic-Inclusion Body Myositis (sIBM). Consistent with these findings, an animal model for hereditary IBM (hIBM), but not their control littermates, revealed deregulated expression of RNF5. Further studies for the role of RNF5 in the pathogenesis of s-IBM and more generally in muscle physiology were performed using RNF5 transgenic and KO animals. Transgenic mice carrying inducible expression of RNF5, under control of beta-actin or muscle specific promoter, exhibit an early onset of muscle wasting, muscle degeneration and extensive fiber regeneration. Prolonged expression of RNF5 in the muscle also results in the formation of fibers containing congophilic material, blue-rimmed vacuoles and inclusion bodies. These phenotypes were associated with altered expression and activity of ER chaperones, characteristic of myodegenerative diseases such as s-IBM. Conversely, muscle regeneration and induction of ER stress markers were delayed in RNF5 KO mice subjected to cardiotoxin treatment. While supporting a role for RNF5 Tg mice as model for s-IBM, our study also establishes the importance of RNF5 in muscle physiology and its deregulation in ER stress associated muscular disorders.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Boonyarom1">[1]</xref>
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Glass1">[2]</xref>
###xml 557 560 557 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Tisdale1">[3]</xref>
Skeletal muscles are continually subjected to remodeling as a consequence of normal mechanical or metabolic stress, as an adjustment of muscle mass to muscle load during normal activity, or as a response to a muscle disease. While exercise leads to increased protein synthesis and build-up of muscle mass (hypertrophy), disuse is associated with degradation of muscle components (atrophy) [1], [2]. Atrophy can also occur during normal aging and as a result of pathological conditions such as primary muscle or peripheral nerve disease, cachexia and cancer [3]. During muscle remodeling, changes in protein turnover due to controlled degradation are balanced by new protein synthesis.
###end p 4
###begin p 5
###xml 382 385 382 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Glass1">[2]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Jackman1">[4]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Reid1">[5]</xref>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Bodine1">[6]</xref>
###xml 800 803 800 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Witt1">[7]</xref>
###xml 803 806 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Clarke1">[8]</xref>
###xml 894 897 894 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Bodine1">[6]</xref>
###xml 899 902 899 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Witt1">[7]</xref>
###xml 1089 1092 1089 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Fielitz1">[9]</xref>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
The ubiquitin-proteasome system (UPS) is a key player in muscle dynamics both in normal and in pathological conditions. The UPS is able to selectively target for degradation structural and regulatory components following their ubiquitination by different E3 ligases. Increased general UPS components, and in particular specific E3 ligases, have been implicated in muscle remodeling [2], [4], [5]. The important role of UPS in muscle atrophy is exemplified by MuRF1, a RING finger E3 ligase, and MAFbx, an F-Box protein component of the Skp1-Cullin F-Box protein (SCF) complex [6]. Increased expression of these ligases in mouse models of muscle disuse results in degradation of structural components of the muscle fibers such as the myofibrillar proteins (myosin, titin, troponin, nebulin, myotilin; [7][8]. Conversely, induced muscle atrophy is prevented in MuRF1 and MAFbx Knockout (KO) mice [6], [7]. The E3 ligase MuRF3 has also been shown to elicit a protective effect on myocardial function through its action on two types of filamins involved in muscle mechanosensing and signaling [9].
###end p 5
###begin p 6
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Hishiya1">[10]</xref>
###xml 271 275 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nastasi1">[11]</xref>
###xml 356 360 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-McElhinny1">[12]</xref>
Other E3 ubiquitin ligases, such as ZNF216, have been implicated in general muscle physiology and muscle atrophy [10]. Ozz-E3 was identified as an E3 ligase that targets sarcolemma-associated beta-catenin for degradation and controls growth and maintenance of myofibrils [11]. A similar role in myofibrillogenesis has been proposed for the MuRF2 E3 ligase [12]. These studies support the notion that E3 ligases are an integral component of muscle dynamics during maintenance of normal muscle function.
###end p 6
###begin p 7
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Frosk1">[13]</xref>
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Schoser1">[14]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Kudryashova1">[15]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Vattemi1">[17]</xref>
In muscle disease, recent evidence supports a role of the UPS in the pathogenesis of select myopathies. Mutations in TRIM32 RING finger E3 ligase have been associated with Limb-Girdle Muscular Dystrophy (LGMD) type 2H [13] and sarcotubular myopathy [14]. Although the mechanism linking TRIM32 ligase activity to LGMD type 2H is unknown, TRIM32 has been shown to interact with myosin and to ubiquitinate actin [15], suggesting a role in myofibrillar turnover during muscle adaptation. Accumulation of ubiquitin-containing cytoplasmic aggregates has been associated with both sporadic and hereditary forms of inclusion-body myositis (sIBM and hIBM). These findings suggest an important role of the UPS in accumulation, misfolding and aggregation of muscle proteins [16]. This has been confirmed by genetic and histopathological analysis that links IBM-like muscle disorders with impairment of the endoplasmic reticulum associated degradation (ERAD) machinery, a degradation pathway important in removal of misfolded proteins [17].
###end p 7
###begin p 8
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 760 764 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 962 966 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 968 972 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Vattemi1">[17]</xref>
###xml 94 99 <span type="species:ncbi:9606">human</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
The sporadic form of IBM (sIBM) is the most common acquired myopathy that occurs in the older human population. sIBM is a slowly progressive myopathy that combines both a T-cell mediated autoimmune inflammatory response and myodegenerative features including vacuolar degeneration, protein aggregation and inclusion formation [16]. Remarkably, sIBM patients are poorly responsive to anti-inflammatory or immunosuppressive treatments, suggesting that inflammation per se may not be a primary cause of the disease [16]. Among current hypotheses, accumulation of malfolded proteins such as amyloid beta Precursor Protein (abetaPP) and its processed forms, and ER overload associated with proteasomal dysfunction are thought to be key players in sIBM pathogenesis [16]. This hypothesis has been further substantiated by the fact that different ER stress markers, such as GRP78 and GRP94 are overexpressed and present in amyloid containing aggregates in sIBM muscles [16], [17], most likely as a consequence of the activation of the Unfolded Protein Response (UPR). Therefore, ER stress induction and impaired clearance of malfolded proteins are thought to be part of the pathogenic process occurring in s-IBM.
###end p 8
###begin p 9
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Kyushiki1">[18]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Matsuda1">[19]</xref>
###xml 157 167 157 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Broday1">[20]</xref>
###xml 256 267 256 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans,</italic>
###xml 412 422 412 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. elegans</italic>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Zengel1">[21]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Broday1">[20]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Didier1">[22]</xref>
###xml 1076 1080 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Younger1">[23]</xref>
###xml 157 167 <span type="species:ncbi:6239">C. elegans</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 256 266 <span type="species:ncbi:6239">C. elegans</span>
###xml 412 422 <span type="species:ncbi:6239">C. elegans</span>
We have previously shown that the RING finger ubiquitin ligase RNF5 (also known as RMA-1; [18], [19]) plays an important role in muscle physiology using the C. elegans model [20]. RNF5 is a membrane-bound E3 ligase that is conserved from worm to human. In C. elegans, RNF-5 localizes to the dense bodies and the M-line of the body wall muscles, where it regulates the levels of the LIM domain protein UNC-95. In C. elegans, UNC-95 has been genetically associated with uncoordinated movement [21] and shown to be important for formation of muscle attachment sites (M-lines and Z-lines) associated with the downstream process of sarcomere organization [20]. In a mammalian cell culture system, RNF5 has been shown to ubiquitinate and regulate the localization of the protein paxillin [22], a critical component of focal adhesion, involved in cell adhesion and motility. More recently, RNF5 has been described as a new component of the ERAD machinery, where it contributes to the ubiquitination-dependent degradation of malfolded proteins as part of cell protein quality control [23].
###end p 9
###begin p 10
###xml 941 945 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 729 737 <span type="species:ncbi:9606">patients</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
###xml 957 962 <span type="species:ncbi:10090">mouse</span>
Here, we have established and characterized inducible transgenic mouse over-expressing RNF5 either ubiquitously or in a muscle specific manner. We show that general as well as tissue specific overexpression of RNF5 induces myofiber degeneration associated with an alteration of endoplasmic reticulum (ER) function. Conversely, RNF5 KO mice exhibit delayed repair of muscle damage associated with attenuated ER stress response. Screening for RNF5 expression in muscle biopsies from patients suffering from muscular disorders including classical myopathies such as Duchenne and Becker myopathy as well as other myopathies with unknown etiology identified upregulation and mislocalization of RNF5 to aggregates in muscles from sIBM patients, as well as in a mouse model for hereditary IBM. Our findings establishes the importance of RNF5 in muscle physiology and in ER stress associated muscular disorders while pointing to the possible use of RNF5 transgenic mouse as a unique model to study the role of ER function in the pathogenesis of degenerative muscle diseases.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 28 33 <span type="species:ncbi:9606">human</span>
Aberrant RNF5 expression in human myopathies
###end title 12
###begin p 13
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001609.s001">Fig. S1</xref>
###xml 740 747 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1A</xref>
###xml 908 915 908 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1B</xref>
###xml 1008 1015 1008 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1C</xref>
###xml 1065 1072 1065 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1D</xref>
###xml 1336 1343 1336 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1E</xref>
###xml 1460 1479 1460 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1E right panel</xref>
###xml 1741 1748 1741 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001609.s002">Fig. S2</xref>
###xml 1878 1882 1878 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 82 87 <span type="species:ncbi:9606">human</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
###xml 519 527 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
###xml 796 804 <span type="species:ncbi:9606">patients</span>
###xml 1210 1215 <span type="species:ncbi:9606">human</span>
###xml 1326 1334 <span type="species:ncbi:9606">patients</span>
###xml 1454 1458 <span type="species:ncbi:10090">mice</span>
To assess whether RNF5 expression or localization would be deregulated in certain human myopathies associated with ER impairment, muscle biopsies from patients affected by different forms of myopathies were screened for possible changes in pattern or level of RNF5 expression using RNF5 antibodies with confirmed specificity developed in our laboratory (Fig. S1). An alteration of RNF5 expression in both vacuolated muscle fibers and in apparently normal fibers (2-20% of total fibers) was detected in biopsies from 10 patients with sIBM. Compared to control muscle, RNF5 in biopsies from sIBM patients was increased in amount and mislocalized, most frequently in apparently non vacuolated muscle fibers and diffusely within the cytoplasm (Fig. 1A). Strikingly, in 3 out of 10 biopsies from sIBM patients, intensive staining for RNF5 was evident with formation of giant aggregates inside some muscle fibers (Fig. 1B). Interestingly, RNF5 inclusions partly co-localized with beta-amyloid positive aggregates (Fig. 1C) but not with phospho-tau containing structures (Fig. 1D). Given the limited expression of RNF5 in skeletal muscle, endogenous RNF5 was not detectable by straight western blots in extracts from human biopsies. Elevated RNF5 protein levels could be observed after RNF5 immunoprecipitation in biopsies from sIBM patients (Fig. 1E). The specificity of the immunoprecipitation reaction was confirmed using muscle extracts from RNF5 KO and WT mice (Fig. 1E right panel). Unlike in sIBM, common muscular dystrophies associated with mutations in proteins of the dystrophin glycoprotein complex (DGC) such as Duchenne or Becker forms of muscular dystrophy, did not exhibit any alteration in the pattern or amount of RNF5 expression (Fig. S2). Since beta-amyloid accumulation and impairment of ERAD and UPR functions are thought to be upstream events in sIBM development [16], our data points to RNF5 deregulation as an early event in the onset of the disease.
###end p 13
###begin title 14
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Alteration of RNF5 pattern is evident in muscle biopsies from both patients with sIBM and in a hIBM mouse model.
###end title 14
###begin p 15
###xml 1446 1450 1446 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Malicdan1">[24]</xref>
###xml 116 124 <span type="species:ncbi:9606">patients</span>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 482 489 <span type="species:ncbi:9606">patient</span>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 835 843 <span type="species:ncbi:9606">patients</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
A. Immunohistological analysis of RNF5 protein in a normal muscle biopsy and in biopsies from 2 representative sIBM patients. RNF5 staining was also positive in aggregates from 10 independent sIBM patients (not shown). B. Muscle cross-sections from 3 sIBM patients immunostained with RNF5 antibody exhibiting high levels of RNF5 protein in giant aggregates. C. Co-localization of RNF5 with beta-amyloid protein (6E10) inclusions in a representative muscle cross-section from a sIBM patient. D. Co-staining of muscle sections from 2 sIBM patients with RNF5 and SMI31, a marker for phospho-tau protein. Arrows point to phospho-tau containing aggregates and arrowheads to RNF5 staining. E. Elevated RNF5 protein levels in biopsies from 3 IBM patients. RNF5 was immunoprecipitated from equal protein amounts prepared from biopsies of sIBM patients using RNF5 polyclonal antibody. The resulting immunoprecipitates were analyzed by western blot using RNF5 antibody. Equal volumes of supernatants from the respective immunoprecipitations were analyzed for GAPDH expression, confirming that the immunoprecipitation reactions were performed using comparable amounts of extracts. F. Immunohistological analysis of RNF5 protein in control (a) and DMRV mutant mice (b-d). c and d represent higher magnification and highlight the presence of dense intrafiber staining for RNF5 in muscle fibers (arrows on panel c point to RNF5 staining within rimmed vacuoles [24] whereas arrow on panel d points to RNF5 staining within centrally located nuclei).
###end p 15
###begin p 16
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Malicdan1">[24]</xref>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g001">Fig. 1F</xref>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Malicdan1">[24]</xref>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
To determine whether changes in amount or localization of RNF5 was a common occurrence in IBM type degenerative myopathies, additional analysis was performed in a mouse model of hereditary IBM, the distal myopathy with rimmed vacuoles (DMRV) mutant mouse [24]. Transgenic animals, but not their control littermates, exhibited a strong increase in RNF5 expression in muscle fibers within areas of regeneration including rimmed vacuoles and centrally located nuclei (Fig. 1F), characteristic of this model [24].These findings reveal altered RNF5 expression in specific degenerative myopathies associated with dysfunction of the ER or the ERAD machinery such as sporadic and hereditary IBM.
###end p 16
###begin title 17
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Construction of RNF5 transgenic mouse
###end title 17
###begin p 18
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 440 447 440 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 466 475 466 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5</italic>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 553 561 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 590 598 590 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 604 608 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA</italic>
###xml 743 750 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g002">Fig. 2A</xref>
###xml 752 756 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Wiekowski1">[25]</xref>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 718 721 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
In order to address the function of RNF5 deregulation in degenerative myopathies, we constructed a transgenic mouse model which allowed conditional RNF5 overexpression. A construct containing the RNF5 gene was cloned downstream of the minimal Tet-ON operator (Tetracyclin Responsive Element (TRE)-containing promotor). RNF5 transgenic (Tg) lines were then established by pronuclear injection and implantation in C57/BL6 recipient mice (see Methods for details). The rtTA RNF5 double transgenic animals (DTg) and their corresponding control littermates (RNF5 STg) were generated by crossing RNF5 STg with rtTA animals, expressing the tetracyclin responsive Transcriptional Activator under the control of the ubiquitous CMV-beta-actin promotor (Fig. 2A; [25].
###end p 18
###begin title 19
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Conditional expression of RNF5 in a transgenic mouse system.
###end title 19
###begin p 20
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA</italic>
###xml 196 200 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 330 334 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA</italic>
###xml 430 443 427 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 962 965 951 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1107 1110 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 150 153 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 163 170 <span type="species:ncbi:9031">chicken</span>
A Schematics depicting transgenic constructs used to overexpress RNF5 in mice. The rtTA transcriptional activator is expressed under the control of a CMV enhancer/chicken beta-actin promoter. The RNF5 transgene is expressed under the control of a tetracycline-responsive promoter and is activated only in the presence of both the rtTA activator and doxycyclin. B. Tissue expression of RNF5 transgene in double transgenic animals. rtTA RNF5 DTg animals were treated with 2 mg/ml of doxycyclin in drinking water for 10 days and RNF5 protein levels were monitored in different organs. RNF5 expression was assessed using RNF5 polyclonal antibody, either by western blotting (skeletal muscle) or after immunoprecipitation (heart, kidney). alpha-tubulin was used as a loading control. In the case of heart and kidney, equal volumes of supernatants obtained following the immunoprecipitation were loaded and probed with alpha-tubulin. C. Comparison of a representative DTg animal overexpressing RNF5 after 4 wk of doxycyclin treatment with its control littermate. D. Weight curve comparison of RNF5-overexpressing DTg animals and their matching controls during doxycyclin treatment. The body mass of individual animals was monitored on a weekly basis for 6 wk. Graphs represent the change in body mass relative to the original weight of a single animal (n = 5). Note: In the same gender and age class, both experimental and control animals had the same external appearance and similar weight at the beginning of treatment.
###end p 20
###begin p 21
###xml 72 85 72 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 138 145 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g002">Fig. 2B</xref>
###xml 274 282 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 648 655 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g002">Fig. 2B</xref>
###xml 936 940 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Wiekowski1">[25]</xref>
###xml 1007 1010 1007 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
Overexpression of RNF5 protein was confirmed in different organs of the rtTA RNF5 DTg animals provided with doxycyclin in drinking water (Fig. 2B). Expression of RNF5 protein was evident in double transgenic animals, but not in doxycyclin-treated single transgenic animals (RNF5 STg) or untreated DTg animals. The RNF5 transgene is expressed at different levels depending on the organs analyzed. The higher level of RNF5 expression was seen in skeletal muscle where RNF5 transgene could be detected by straight western blot. RNF5 was expressed to a lesser extent in heart and in kidney where immunoprecipitation was required to detect the protein (Fig. 2B). Conversely, RNF5 levels were very low in liver and undetectable in brain, lungs and spleen (data not shown). This expression pattern is consistent with the low transcriptional levels of the rtTA activator and the differential expression pattern described for the rtTA transgene [25]. These data suggest that RNF5 expression is tightly controlled in DTg mice and that the system is not subjected to transcriptional leakage in the absence of doxycyclin induction. Furthermore, the expression of RNF5 in skeletal muscles makes it a suitable system for studying its function in this organ, without restricting its expression to mature muscle fibers.
###end p 21
###begin title 22
Induction of RNF5 transgene leads to rapid weight loss and early onset of muscle wasting and kyphosis
###end title 22
###begin p 23
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 141 153 141 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g002">Figs. 2C, 2D</xref>
###xml 344 355 344 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g002">Fig. 2C, 2D</xref>
rtTA RNF5 DTg but not control animals subjected to doxycyclin treatment exhibited a significant weight loss as early as 2 wk post-induction (Figs. 2C, 2D). By 4 wk, clear phenotypic differences were evident between the double transgenic animals and their control littermates, including a significant decrease in body mass and visible kyphosis (Fig. 2C, 2D). After 5-6 wk of RNF5 overexpression, the phenotype was even more severe: the animals showed decreased activity and pelvic limb weakness. Death eventually occurred 7 weeks following initiation of doxycyclin treatment.
###end p 23
###begin p 24
###xml 221 230 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g003">Fig. 3A&#8211;C</xref>
###xml 939 946 939 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g003">Fig. 3C</xref>
###xml 1043 1050 1043 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g003">Fig. 3D</xref>
###xml 1219 1226 1219 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g003">Fig. 3E</xref>
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
Skeletal muscles were collected from double transgenic mice and analyzed for histopathologic changes. Compared with controls, double transgenic animals exhibit clear pathological changes in all skeletal muscles analyzed (Fig. 3A-C). In transverse sections of fresh frozen specimens from the triceps brachii, tibialis anterior and vastus lateralis muscles, there was a marked variability in myofiber size in the treated double transgenic animals, with numerous small caliber fibers having a round shape, and multifocal clusters of mononuclear cells. As there was no elevation of atrogin-1 in the muscle from the double transgenic animals, the decrease in fiber size was not likely a result of muscle atrophy (data not shown). Many muscle fibers of both small and larger caliber contained internal nuclei. Measurement of the cross-sectional area confirmed the presence of many small fibers, most markedly within the vastus lateralis muscle (Fig. 3C). The small size of the muscle fibers was reflected by a decrease in the weight of each muscle (Fig. 3D). Loss of muscle mass may account for the global decrease in body weight observed in the double transgenic animals, as the weight of the other organs was not affected (Fig. 3E). Of the different muscles analyzed, the vastus lateralis was the most affected, demonstrated both by decreased cross-sectional area measurement and more pronounced weight loss.
###end p 24
###begin title 25
RNF5-overexpression is associated with muscle fiber degeneration.
###end title 25
###begin p 26
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 141 154 141 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 247 248 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 415 423 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 428 441 424 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 643 651 639 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 656 669 652 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
A-C Cross-sections of fresh frozen specimens of triceps brachii (A), tibialis anterior (B) and vastus lateralis (C) muscles from RNF5 STg or rtTA RNF5 DTg animals treated with doxycyclin for 6 wk (H&E stain). Fiber cross-sectional area (CSA microm2) corresponding to each muscle type was calculated and plotted as a percentage of the total number of fibers analyzed (n>200) (right panel). D. Average muscle mass of RNF5 STg and rtTA RNF5 DTg animals treated with doxycyclin for 6 wk. Each muscle was extracted, trimmed under the microscope and weighed on a precision scale (n = 5 for experimental and control groups). E. Average organ mass of RNF5 STg and rtTA RNF5 DTg animals treated with doxycyclin for 6 wk.
###end p 26
###begin title 27
RNF5 overexpression is associated with increased muscle degeneration and extensive regeneration
###end title 27
###begin p 28
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4A</xref>
###xml 320 333 320 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4B</xref>
###xml 539 552 539 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 648 661 648 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 740 747 740 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4C</xref>
###xml 891 898 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4C</xref>
###xml 1127 1130 1127 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1229 1236 1229 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4D</xref>
###xml 1378 1385 1378 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4D</xref>
Although vacuolated fibers were not observed, rtTA RNF5 DTg animals exhibit myodegeneration, supported by various stages of myonecrosis and phagocytosis based on modified Gomori-trichrome stain (Fig. 4A). Levels of serum creatine kinase (CK) activity were consistently elevated after 6 wk of doxycyclin treatment in the rtTA RNF5 DTg animals, but not in their control littermates (Fig. 4B), supporting the presence of myofiber damage. To visualize the extent and distribution of myodegeneration, Evans Blue dye (EBD) was injected into the rtTA RNF5 DTg and their control littermates. Contrary to the skeletal muscle of their matching controls, the rtTA RNF5 DTg animals exhibited positive staining for EBD within a number of muscle fibers (Fig. 4C), consistent with degeneration (myonecrosis) and elevated serum CK activity. EBD-positive muscle fibers were negative for dystrophin staining (Fig. 4C) and surrounded by immune cells that showed positive staining for the pan-leukocyte marker CD45 and macrophage marker CD11b (data not shown), corresponding to macrophages clearing up necrotic debris. Ultrastructural analysis on DTg muscles further confirmed that the sarcomeric structure was conserved in non-degenerative fibers (Fig. 4D asterisk). In degenerating fibers, there was loss of the normal myofibrillar pattern, mitochondrial swelling and dilated tubular structures (Fig. 4D).
###end p 28
###begin title 29
RNF5 induced myodegeneration is associated with extensive myofiber regeneration.
###end title 29
###begin p 30
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STg</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 268 281 268 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 326 329 326 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 489 492 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1383 1386 1383 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1580 1583 1580 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 2146 2159 2142 2155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 2172 2180 2168 2176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 2320 2333 2316 2329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 1926 1930 <span type="species:ncbi:10090">Mice</span>
###xml 2282 2287 <span type="species:ncbi:10090">mouse</span>
A. Modified Gomori-trichrome staining of triceps brachii cross-sections from treated STg and DTg animals. DTg muscle sections show a number of degenerative fibers with cellular infiltration (arrows). B. Serum creatine kinase (CK) levels were monitored in RNF5 STg and rtTA RNF5 DTg after 4 wk of doxycyclin treatment (n = 3). DTg animals had variably elevated CK levels. C. Dye-permeable fibers are surrounded or invaded by macrophagic inflammatory cells clearing necrotic debris. Treated DTg and control mice were injected with Evans Blue Dye (EBD) 12 hr before sacrificed and fiber permeability to the dye was monitored externally by the blue coloration of the muscles (right panel) and after cross-section (red fluorescence; left panel). The muscle cross-sections were counterstained with an antibody against dystrophin to visualize fiber boundaries and to highlight degenerative myofibers where staining for dystrophin was absent. D. Ultrastructural analysis of DTg muscle sections. In longitudinal sections, sarcomere structure was normal in non-degenerating myofibers (left, asterisks). In an adjacent degenerating fiber, disruption of sarcomere structure, dilated tubular structures (arrows), and enlarged mitochondria (arrowheads) are evident. A similar pattern was evident in cross-section (right panel). Magnificationx11,000. E. Muscle cross-sections of doxycyclin-treated DTg and control animals stained with antibodies against embryonic myosin heavy chain (embMHC) and myogenin. Arrowheads indicate some nuclei exhibiting a positive myogenin staining in sections from DTg animals. Muscle sections were counterstained with anti-laminin alpha3 antibody (red) and DAPI (blue) to visualize respectively myofiber boundaries and nuclei. F. Quantification of the number of regenerative myofibers, expressed as the average number of embMHC positive fibers (early regenerative fibers) and of centrally nucleated fibers. G. Mice overexpressing RNF5 have extensive mononuclear cell infiltration in areas of myofiber degeneration. Cd11b immunostaining (arrowheads) highlight macrophagic infiltration of triceps brachii muscle cross-sections from rtTA RNF5 DTg (b) but not RNF5 STg (a) animals treated with doxycyclin for 6 wk. Nuclei are stained with DAPI (blue). Negative control (mouse IgG) performed on sections from rtTA RNF5 DTg is shown in panel (c). (d) Muscle regeneration associated with RNF5 overexpression does not result in fibrosis. Triceps cross-sections from RNF5 STg and DTg animals were stained with modified Gomori-Trichrome.
###end p 30
###begin p 31
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 161 174 161 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 368 377 368 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4E,F</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Charge1">[26]</xref>
###xml 576 589 576 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 642 649 642 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4E</xref>
###xml 775 782 775 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4G</xref>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g004">Fig. 4G</xref>
Myodegeneration in RNF5 overexpressing animals was associated with extensive fiber regeneration. Quantitative analysis revealed that 50% of the muscle fibers of rtTA RNF5 DTg, but not control animals, were centrally nucleated, and that 30% of the small fibers stained positively for embryonic myosin heavy chain (emb MHC), a known marker of early muscle regeneration (Fig. 4E,F). Consistent with this observation, positive staining for myogenin, a transcription factor expressed during differentiation of activated satellite cells[26], was also observed in small myofibers of rtTA RNF5 DTg animal muscle but not in their control littermates (Fig. 4E). Interestingly, clusters of mononuclear cells, staining positively with antibodies against CD45 (data nor shown) and CD11b (Fig. 4G), were also observed at sites of muscle regeneration, yet, neither lymphocytic infiltration nor fibrosis were observed (Fig. 4G, and data not shown). These data indicate that regeneration following overexpression of RNF5 is a result of myofiber degeneration and not an inflammatory process.
###end p 31
###begin p 32
###xml 192 195 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 217 224 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001609.s003">Fig. S3</xref>
###xml 353 361 349 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 605 612 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001609.s004">Fig. S4</xref>
Immunostaining using markers for DGC proteins including dystrophin and alpha-sarcoglycan, as well as the extracellular matrix protein laminin alpha2, did not show any major difference between DTg and control muscles (Fig. S3), indicating that disruption of the DGC or extracellular matrix proteins was not a primary cause for myonecrosis. Consistently, in vitro differentiation of primary myoblasts cultured from the double transgenic animals treated with doxycyclin prior and during differentiation did not reveal changes in the sarcomeric structure as depicted by staining for alpha-sarcomeric actinin (Fig. S4). Taken together, these findings demonstrate that myofiber degeneration and necrosis account for the elevated serum CK activity associated with RNF5 overexpression, and that myodegeneration is not a primary inflammatory process nor is it a consequence of the alteration of common sarcolemmal structural proteins.
###end p 32
###begin title 33
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Myofiber degeneration-coupled regeneration in rtTA RNF5 DTg mice is associated with altered expression of ER chaperones without the formation of protein aggregates
###end title 33
###begin p 34
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Askanas1">[16]</xref>
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Vattemi1">[17]</xref>
###xml 336 349 336 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 372 379 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5A</xref>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 547 554 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5B</xref>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5B</xref>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 610 618 <span type="species:ncbi:9606">patients</span>
Given the link between ER stress and sIBM [16], [17] we next examined the status of ER stress markers in the muscles of RNF5 overexpressing animals. Consistent with the increase in ER stress markers observed in s-IBM muscles, a clear and consistent, albeit moderate, increase in expression of PDI, Grp78, Grp94 and calnexin was seen in rtTA RNF5 DTg but not control mice (Fig. 5A), suggesting that ER stress occurs in the muscles of RNF5 overexpressing animals. Grp94 upregulation was confirmed by immunohistochemistry of the DTg muscle sections (Fig. 5B). However, contrary to what has been observed in s-IBM patients, this ER chaperone did not localize to aggregates (Fig. 5B) and congophilic material was not detected in the muscle fibers of DTg animals (data not shown). These data suggest that the myodegeneration observed following RNF5 overexpression is associated with ER stress yet occurs at earlier stage in the development of this disease, prior to aggregate formation.
###end p 34
###begin title 35
RNF5 localizes to the ER and its overexpression correlates with altered ER function.
###end title 35
###begin p 36
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 184 192 180 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 196 209 192 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 493 496 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 501 504 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STg</italic>
###xml 605 608 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
A. Expression levels of select ER stress markers in muscles of DTg animals are elevated compared to their control littermates. Western blot analysis of muscle extract (80 microg) from RNF5 STg or rtTA RNF5 DTg animals treated for 6 weeks with doxycyclin was probed with Grp78, PDI, Grp94, calnexin and CHOP antibodies. RNF5 and GAPDH antibodies were used for RNF5 expression and loading controls, respectively. B. Grp94 immunostaining of vastus lateralis cross-sections from treated rtTA RNF5 DTg and STg animals. C. RNF5 localizes to the ER of muscle fibers. Vastus lateralis cross-sections from treated DTg animals were stained with RNF5 antibody. Normal (top panels) or regenerative fibers (bottom panels) are shown for RNF5 staining alone (left panels) or combined with DAPI (right panels).
###end p 36
###begin p 37
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Xu1">[27]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Kaufman1">[28]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nakanishi1">[29]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Tarricone1">[30]</xref>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 663 670 663 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5A</xref>
###xml 849 862 849 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
ER stress is commonly considered a protective response. However, high levels of ER stress or ER dysfunction may also impair cell survival by triggering apoptotic pathways (review by [27]. Therefore, the onset of ER stress could cause fiber death with concomitant induction of muscle regeneration without directly affecting the muscle structural components [28], [29], [30]. Analysis of TUNEL and cleaved caspase 3 as markers of apoptosis did not reveal any changes in programmed cell death (data not shown). Similarly, no increase was observed in the levels of CHOP or in cleavage of caspase 12 (data not shown). Rather CHOP levels were decreased in DTg animals (Fig. 5A), implying that overexpression of RNF5 may induce ER stress by limiting the activation of some UPR components. These data also indicate that the degeneration process observed in rtTA RNF5 DTg animals is not linked with ER-associated programmed cell death.
###end p 37
###begin p 38
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Gorza1">[31]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Tarricone1">[30]</xref>
###xml 369 382 369 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5A</xref>
###xml 576 583 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5C</xref>
###xml 722 729 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g005">Fig. 5C</xref>
###xml 559 574 <span type="species:ncbi:10090">transgenic mice</span>
Grp94 was previously reported to be important for myoblast fusion [31], a critical step in regenerating muscle. Change in Grp94 levels and localization is expected to impact its contribution to myoblast fusion and therefore affect the regeneration process [30]. Analysis of GRP94 expression revealed increased expression and possible post translational modification in rtTA RNF5 DTg but not in their matching controls (Fig. 5A). Further, RNF5 staining exhibited dense perinuclear staining in the endoplasmic reticulum of mature and regenerative fibers of the transgenic mice (Fig. 5C). Notably, RNF5 staining was higher in regenerating fibers and localized along the nascent sarcoplasmic reticulum network and sarcolemma (Fig. 5C), suggesting that its function may prevail during the regeneration process. These findings suggest that RNF5 may exert its effect on muscle physiology by modulating the function/localization of specific components of the ER, including Grp94.
###end p 38
###begin title 39
Long-term muscle-specific overexpression of RNF5 results in muscle degeneration and regeneration and vacuole formation
###end title 39
###begin p 40
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6A</xref>
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Ghersa1">[32]</xref>
###xml 525 541 525 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 572 580 572 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 686 690 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 892 899 889 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6B</xref>
###xml 1117 1133 1114 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1198 1201 1195 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STg</italic>
###xml 1203 1210 1200 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6C</xref>
###xml 1327 1343 1324 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1533 1546 1527 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 1576 1592 1570 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1671 1678 1665 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6D</xref>
###xml 1801 1814 1795 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 1858 1874 1852 1868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1932 1950 1926 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6D panels c,d</xref>
###xml 2017 2035 2011 2029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6D panels e&#8211;h</xref>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 1448 1452 <span type="species:ncbi:10090">mice</span>
###xml 1547 1551 <span type="species:ncbi:10090">mice</span>
###xml 1593 1597 <span type="species:ncbi:10090">mice</span>
###xml 2340 2348 <span type="species:ncbi:9606">patients</span>
In order to analyze the effect of RNF5 overexpression in a tissue specific manner and to confirm that the phenotype observed originates from RNF5 expression in mature muscles, we crossed RNF5 transgenic animals with mice expressing the tTA transgene under the control of the muscle specific promoter MCK (Muscle Creatine Kinase) (Fig. 6A). This mouse model was previously generated to control conditional gene expression in skeletal muscles in a tetracyclin repressible manner [32]. In this model, double transgenic animals (MCK-tTA RNF5 DTg) and their matching controls (RNF5 STg) were kept under doxycyclin treatment until they reached 3 months of age to prevent the induction of the RNF5 transgene. Specific overexpression of RNF5 in skeletal muscle was then induced following doxycylin withdrawal. RNF5 level of expression was comparable to the one we observed using beta-actin promoter (Fig. 6B). When expressed from a muscle-specific promoter, RNF5 overexpression led to a less severe, albeit clear and reproducible clinical phenotype, with animals surviving up to 5 month after initiating transgene induction. MCK-tTA RNF5 DTg were found to exhibit a mild weight loss over time, compared to STg (Fig. 6C). This milder phenotype enabled us to monitor the effect of RNF5 overexpression over a prolonged time period. While MCK-tTA RNF5 DTg animals exhibited histopathological changes similar to those observed in the beta-actin expressing RNF5 mice, only few animals exhibited these phenotype within the same time frame seen for rtTA RNF5 DTg mice (6 wk). The majority of MCK-tTA RNF5 DTg mice exhibit a clear muscle phenotype only 20 wk after doxycyclin withdrawal (Fig. 6D panels a,b). Strikingly, in addition to the classical myodegeneration and regeneration process previously observed in the rtTA RNF5 DTg model, prolonged expression of RNF5 in the MCK-tTA RNF5 DTg also caused the appearance of Congo Red positive fibers (Fig. 6D panels c,d) and the formation of blue-rimmed vacuoles containing inclusions (Fig. 6D panels e-h). These findings establish that muscle-specific overexpression of RNF5 is sufficient to cause muscle degeneration with extensive muscle regeneration. Moreover, prolonged RNF5 overexpression leads to the formation of vacuole containing inclusions and accumulation of congophilic material, as seen in sIBM patients, further substantiating a role for RNF5 in the development of the disease.
###end p 40
###begin title 41
Long term muscle specific expression of RNF5 results in the formation of vacuoles containing aggregates.
###end title 41
###begin p 42
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 390 406 390 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA</italic>
###xml 481 497 481 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 949 970 949 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg (a, c, e, g)</italic>
###xml 974 990 974 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1298 1314 1298 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 1483 1486 1483 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DTg</italic>
###xml 1491 1494 1491 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STg</italic>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
A. Schematics depicting transgenic constructs used to overexpress RNF5 in a muscle specific manner. The tTA transcriptional activator is expressed under the control of the Muscle Creatine Kinase (MCK) promoter and is inactive in the presence of doxycyclin. Once doxycyclin is withdrawn, tTA activates the expression of the RNF5 transgene. B. Muscle specific expression of RNF5 transgene in MCK-tTA RNF5 DTg transgenic animals. RNF5 protein levels in vastus lateralis from rtTA and MCK-tTA RNF5 DTg and RNF5 STg mice were monitored by western blot, 20 wk after doxycyclin withdrawal. C. Weight curve comparison of MCK-tTA RNF5-overexpressing DTg animals and their matching controls after doxycyclin withdrawal. The body mass of individual animals was monitored for 20 wk. Graphs represent the change in body mass relative to the original weight of a single animal (n = 5). D. Cross-sections of fresh frozen specimens of vastus lateralis muscles from RNF5 STg (a, c, e, g) or MCK-tTA RNF5 DTg (b, d, f, h) animals 20 wk after doxycyclin withdrawal. H&E (a, b, e, f) and congo red (c, d) stain have been performed on triceps cross-section. Panels f and g represent a higher magnification to better visualize the presence of vacuole containing aggregates (arrows). E. Expression of GRP94 in muscles of MCK-tTA RNF5 DTg animals compared to their control littermates, 6 wk and 20 wk after doxycyclin withdrawal. F. GRP94 immunostaining of vastus lateralis cross-sections from MCK-tTA RNF5 DTg and STg animals 20 wk after doxycyclin withdrawal.
###end p 42
###begin p 43
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 151 167 151 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCK-tTA RNF5 DTg</italic>
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6E</xref>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g006">Fig. 6F</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
Similar to what we have observed in rtTA RNF5 DTg mice, ER stress markers such as GRP94 was up regulated (possibly a post-translationally modified) in MCK-tTA RNF5 DTg animals (Fig. 6E) and elevated expression was observed in small regenerating fibers by immunohistochemistry (Fig. 6F). The two mouse models used provide important confirmation for the role of RNF5 in ER stress-associated muscle degeneration phenotype.
###end p 43
###begin title 44
###xml 8 12 <span type="species:ncbi:10090">mice</span>
RNF5 KO mice exhibit a delay in regeneration from cardiotoxin-induced muscle damage
###end title 44
###begin p 45
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7A</xref>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 293 314 293 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 648 655 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7A</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
To further assess the potential role of RNF5 in normal muscle physiology we used an RNF5 KO model established in our laboratory. In these mice, exons 1-3 of the RNF5 gene were replaced by a Neo cassette (Fig. 7A). The chimeric mice gave a germline transmission of the disrupted RNF5 gene (see Materials and Methods for further details) and heterozygous mice were interbred to produce litters that included homozygous offspring. Southern blot analysis of mouse DNAs isolated from the tails of these mice revealed the expected three genotypes (+/+, +/-, -/-), as judged by diagnostic probes for the correct 5' and 3' homologous recombination events (Fig. 7A).
###end p 45
###begin title 46
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Delayed Muscle regeneration in RNF5 KO mouse subjected to muscle damage by cardiotoxin treatment.
###end title 46
###begin p 47
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
A. Generation of RNF5 KO mouse. Schematic of RNF5 genomic structure (upper) and targeting vector (lower) are shown. Restriction enzyme sites (K: KpnI, Xh: XhoI, S: SalI) are marked. Location of the primers for PCR and the probe for Southern blotting are indicated. Exons 1, 2 and 3 including the translational start site (ATG) and RING finger domain are substituted with neo cassette. Southern blot for analysis of RNF5 gene is shown on the right panel. DNA isolated from the tails of +/+, +/-, and -/- mice was digested with EcoRI and resolved by electrophoresis through 0.8% agarose gels. After transferring to nitrocellulose paper, blots were hybridized with radiolabeled cDNA probes corresponding to the fragment indicated in diagram. B. Protein extracts from cardiotoxin and PBS treated tibialis muscles from WT and RNF5 KO animals were analyzed by western blots with the indicated antibodies to monitor changes in endogenous RNF5 as well as ER stress and muscle markers. Ponceau staining is used as a loading control. C. Cross section of tibialis anterior from WT and RNF5 KO mice performed 28 days after cardiotoxin treatment.
###end p 47
###begin p 48
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-dAlbis1">[33]</xref>
RNF5 KO and WT animals were subjected to cardiotoxin treatment, which induces muscle damage followed by its regeneration [33], thereby allowing us to monitor possible changes in the ability of each genotype to promote muscle regeneration. The toxin, or PBS control, was injected directly into the tibialis muscle and the muscles were collected after 3, 4, 6, 12 and 28 days.
###end p 48
###begin p 49
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7B</xref>
###xml 575 582 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7B</xref>
###xml 587 594 587 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001609.s005">Fig. S5</xref>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
Significantly, the expression of RNF5 in WT muscle was elevated after cardiotoxin treatment (Fig. 7B), thereby supporting a role for RNF5 in muscle physiology/regeneration. To assess whether increase of RNF5 levels in physiological conditions would affect ER stress markers, we monitored the levels of GRP94 in RNF5 KO and WT during the course of muscle regeneration. Importantly, both induction of Grp94 expression and its post translational modification, as defined by the disappearance of the slower migrating form, were delayed in RNF5 KO mice, compared with WT animals (Fig. 7B and Fig. S5). Of interest, induction of calnexin was slightly delayed whereas expression of PDI was elevated in RNF5 KO.
###end p 49
###begin p 50
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7B</xref>
###xml 352 359 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001609-g007">Fig. 7C</xref>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Consistent with the changes observed in induction of ER stress markers, muscle regeneration in RNF5 KO mice was attenuated, compared to control animals, as evident from (i) delayed production of myosin heavy chain (Fig. 7B) and (ii) a high number of centrally nucleated fibers observed 28 days after cardiotoxin treatment in the KO but not WT animals (Fig. 7C). These data substantiate the observations made with RNF5 Tg mice and suggest that RNF5 is playing an important role in muscle regeneration process associated with ER stress response.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 855 859 <span type="species:ncbi:10090">mice</span>
###xml 1376 1381 <span type="species:ncbi:10090">mouse</span>
The present study establishes a link between RNF5 and specific muscular disorders associated with ER stress. Prompted by our observation that RNF5 is overexpressed and mislocalized to aggregates in muscle biopsies from sIBM patients and deregulated in an animal model for hereditary IBM, we have investigated the role of RNF5 in muscle using 3 genetic mouse models: an inducible transgenic mouse in which the E3 ligase RNF5 is conditionally overexpressed (globally and selectively in skeletal muscle) and an RNF5 KO mouse. RNF5 overexpression led to myodegeneration and regeneration in skeletal muscle independent of the classical dystrophic mechanism of sarcomeric disruption. In addition, prolonged RNF5 overexpression leads to the formation of blue-rimmed vacuoles containing inclusions and congo red positive fibers, as seen in sIBM. Further, RNF5 KO mice subjected to muscle damage exhibited a milder muscle phenotype which is consistent with a slower regenerative process. Both RNF5 overexpression and KO models suggest that the muscle phenotypes are associated with altered ER stress response, as shown by the increase in the ER stress markers PDI, GRP78, GRP94 and calnexin in the muscle of the RNF5-overexpressing animals and the delay in GRP94 and calnexin induction in RNF5 KO. These observations establish a link between RNF5, ER stress and muscle physiology. The mouse lines established and characterized in this study offer new models to study ER-related myodegenerative process that occur in myopathies such as sporadic or hereditary IBM.
###end p 52
###begin p 53
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Kim1">[34]</xref>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 476 484 <span type="species:ncbi:9606">patients</span>
Impairment of the ERAD and UPR pathways has been linked with the onset of degenerative diseases such as sIBM, and is thought to have a contributing role by allowing improper accumulation of malfolded proteins. Consistent with this hypothesis, we found that RNF5, an E3 ligase involved in ERAD, exhibit an altered pattern of expression in biopsies from sIBM patients. Interestingly, RNF5 has also been shown to be upregulated in brain (Substantia Nigra) from Parkinson Disease patients [34], therefore pointing to a possible broader role of this E3 ligase in degenerative disorders. The increase in RNF5 expression seen in these degenerative diseases could be a consequence of ER overload, ERAD dysfunction, or part of the mechanism engaged in the development of these disorders. Our data supports the latter possibility since RNF5 overexpression is sufficient to induce the myodegenerative process associated with both the formation of blue-rimmed vacuole over time and an elevation of ER stress markers, characteristic of sIBM. Our observation that RNF5 over-expression was not sufficient to promote the formation of vacuoles containing inclusions at an early time point when ER stress markers were already upregulated suggests that ER stress and RNF5 overexpression are among early events in the pathology of these muscle disorders.
###end p 53
###begin p 54
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
That RNF5 is deregulated in the DMRV mouse model, where a sialation defect has previously been shown to promote the IBM-like phenotype, implies that RNF5 deregulation may not be the primary cause for the disease but rather be one of the early components contributing to the pathological process.
###end p 54
###begin p 55
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Younger1">[23]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Watts1">[35]</xref>
###xml 1067 1071 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Janiesch1">[36]</xref>
###xml 1073 1077 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Landsverk1">[37]</xref>
###xml 1378 1382 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nagaraju1">[38]</xref>
###xml 1565 1569 1565 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nagaraju1">[38]</xref>
###xml 1571 1575 1571 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nagaraju2">[39]</xref>
###xml 615 620 <span type="species:ncbi:10090">mouse</span>
###xml 1354 1359 <span type="species:ncbi:9606">human</span>
###xml 1369 1377 <span type="species:ncbi:9606">patients</span>
Among mechanisms that may account for the ability of RNF5 to cause myodegeneration is the effect of RNF5 on ER stress response and ERAD. RNF5 contributes to ubiquitination of misfolded proteins, with a concomitant effect on their clearance of the proteins by the proteasomes [23]. RNF5 also controls ERAD through its effect on JAMP, an ER anchored 7 transmembrane protein which is important for proteasome recruitment to the ER (our unpublished observation). Thus, RNF5 overexpression is expected to impair the ER stress response, consistent with the modification of ER stress associated chaperones observed in our mouse model. Of importance is that accumulating pathological evidence now links mutations or dysregulation of ER-related proteins with muscular disorders. For example, mutations in the ER-associated ATPase p97/VCP have been associated with a specific type of inclusion body myopathy associated with Paget disease [35]. In addition, the p97/VCP and ERAD pathways were recently implicated in the degradation of sarcomeric myosin and its chaperone Unc-45 [36], [37], thereby offering a link between physiologic ER function and the organization of essential structural muscle components. Further, activation of ER stress was implicated in an animal model of autoimmune myositis with increased expression of MHC class I in muscle fibers and in human myositis patients [38]. ER overload may be sufficient to trigger muscle regeneration prior to, and independently of, the onset of inflammation, supporting ER dysfunction as a primary cause of fiber damage [38], [39]. Thus, RNF5 overexpression may impair the ER function, ultimately leading to a defect in the process of muscle maintenance.
###end p 55
###begin p 56
###xml 279 287 279 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nakanishi1">[29]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Gorza1">[31]</xref>
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-AcostaAlvear1">[40]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Blais1">[41]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Nakanishi2">[42]</xref>
###xml 1276 1280 1276 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Iioka1">[43]</xref>
###xml 1674 1678 1674 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Grossman1">[44]</xref>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1216 1223 <span type="species:ncbi:8355">Xenopus</span>
Independent evidence also supports the fact that ER-associated processes are physiologically relevant during muscle regeneration. The chaperone protein GRP94 and the ER-stress-responsive transcription factor ATF6 were upregulated and required for proper myoblast differentiation in vitro[29], [31]. UPR has recently been proposed to be part of a quality control mechanism that determines proper muscle differentiation. In this model, the induction of certain UPR components, such as the transcription factor Xbp1, is used as a threshold to determine the progression of the myoblast into the differentiation program and the survival of the differentiated fiber [40], [41], [42]. Deregulation of RNF5 in this context is expected to interfere with the balance of these components most probably as a downstream component of this system, therefore altering the differentiation and the muscle maintenance programs. Of interest, RNF5 E3 ligase activity does not appear to be required for the muscular phenotype, as Tg mice that expresses RING mutant form of RNF5 exhibits similar phenotypes (data not shown). Consistent with this observation, a close homolog of RNF5, RNF185, was shown to control paxillin turn-over during Xenopus development independently of its E3 ligase activity [43]. Among possibilities to explain ubiquitin ligase independent effect of RNF5 is that RNF5 may impair muscle function by squelching or recruiting components of the ER machinery, by outcompeting its associated ligases (i.e. CHIP or gp78), or by acting as an E4 ligase on specific substrates after their ubiquitination by another E3 for which ligase activity may not always be required (i.e. p300 [44]).
###end p 56
###begin p 57
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
In conclusion, the characterization of the RNF5 transgenic and KO mouse models establishes an undisclosed link between impaired ER stress response and the early changes in degenerative myopathies, shown here for sIBM, while offering a novel model for studying the complex function of the ER in global muscle physiology.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 19 34 <span type="species:ncbi:10090">transgenic mice</span>
Generation of RNF5 transgenic mice
###end title 59
###begin p 60
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 542 550 542 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA Tg</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 675 678 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Mouse studies were performed under IACUC approvals from MSSM and BIMR. The mouse isoform of the RNF5 gene was cloned by PCR in frame with the HA tag into the pTRE2-HA vector using MluI and NheI restriction sites and sequenced. The linear fragment resulting from a HpaI-SapI digestion was then used for pronuclear injection. After microinjection into B6C3 (C57BL/6xC3H) F2 hybrid eggs, the fertilized eggs were transferred into C57/BL6 female recipients and crossed with C57/BL6 males. Conditional RNF5 overexpression was achieved by crossing RNF5 STg animals with rtTA Tg mice, expressing the tetracycline-responsive Transcriptional Activator under control of the ubiquitous CMV-beta-actin promoter, and the genotypes were verified by PCR reaction using the following primers (RNF5-forward:
###end p 60
###begin p 61
###xml 0 27 0 27 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTACCCATACGATGTTCCAGATTACGC</named-content>
GTACCCATACGATGTTCCAGATTACGC;
###end p 61
###begin p 62
###xml 14 41 14 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTGAGCAGCCAGAAAAAGAAAAAGATG</named-content>
RNF5-reverse: CTGAGCAGCCAGAAAAAGAAAAAGATG;
###end p 62
###begin p 63
###xml 14 38 14 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGGGTCTACCATCGAGGGCCTGCT</named-content>
rtTA-forward: CGGGTCTACCATCGAGGGCCTGCT;
###end p 63
###begin p 64
###xml 14 38 14 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCCGGGGAATCCCCGTCCCCCAAC</named-content>
rtTA-reverse: CCCGGGGAATCCCCGTCCCCCAAC);
###end p 64
###begin p 65
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA</italic>
Both RNF5 and rtTA transgenic lines were kept as heterozygous and maintained as separate lines by crossing with WT C57/BL6 animals.
###end p 65
###begin p 66
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
MCK-tTA transgenic animals were obtained from Taconic Farms, as a repository for NIH deposited mouse strains and genotypes using the same primers as for rtTA animals.
###end p 66
###begin title 67
Immunoblot and immunohistochemistry analysis
###end title 67
###begin p 68
###xml 577 583 <span type="species:ncbi:9986">rabbit</span>
###xml 604 610 <span type="species:ncbi:9986">rabbit</span>
###xml 629 634 <span type="species:ncbi:10090">mouse</span>
For expression analysis, frozen tissues were collected, flash frozen and pulverized using a mortar and pestle in liquid nitrogen. Proteins were extracted by resuspension in cold RIPA buffer containing anti-proteases and the extracts homogenized and clarified by high speed centrifugation. The protein concentration in the supernatant was determined by Bradford assay. RNF5 expression was analyzed either by straight immunoblot or after immunoprecipation using an affinity-purified RNF5 polyclonal antibody (1:2000 dilution). Expression for ER stress markers was assessed using rabbit GRP78 (Santa Cruz), rabbit GRP94 (Abcam) and mouse PDI (StressGene) antibodies and using GAPDH (Ambion) as a control.
###end p 68
###begin p 69
For immunohistochemistry analysis, skeletal muscle tissues embedded in O.C.T. Compound (Sakura Tissue-Tek, product #4583) were pinned on cork pieces and snap-frozen in isopentane cooled in liquid nitrogen. Frozen tissues were stored at -80degreesC until cross-sections (8 microm thick) were prepared using a Leica CM3050S cryostat and stained.
###end p 69
###begin p 70
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Dubowitz1">[45]</xref>
###xml 638 644 <span type="species:ncbi:9986">Rabbit</span>
###xml 721 726 <span type="species:ncbi:10090">mouse</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
###xml 841 846 <span type="species:ncbi:10090">Mouse</span>
###xml 850 855 <span type="species:ncbi:10090">Mouse</span>
###xml 882 885 <span type="species:ncbi:10116">rat</span>
###xml 890 896 <span type="species:ncbi:9986">rabbit</span>
H&E stainings and Gomori-Trichrome were performed as previously described [45]. For immunostaining, sections were fixed in cold acetone for 5 min, permeabilized with 0.1% Triton X for 10 min and blocked with 1% glycine for 30 min. Immunostainings were performed using dystrophin antibody (Vector clone Dy8/6C5, diluted 1:20), CD45 (BD Pharmingen, clone 30-F11, diluted 1:200), Cd11b (BD Pharmingen, clone M170, diluted 1:100), embMHC (hybridoma bank F1.652, diluted 1:3), myogenin (hybridoma bank F5D, diluted 1:100), laminin alpha2 antibody (abcam 4H8-2,). RNF5 polyclonal antibody generated using full length bacterially produced RNF5. Rabbit's serum was purified on RNF5 affinity column and used (dilution 1:100). For mouse monoclonal antibodies, the sections were incubated in biotinylated anti-mouse and avidin-conjugated fluorescein. (Mouse on Mouse Kit, Vector #FMK2201) For rat and rabbit antibodies, the sections were incubated with alexa fluor conjugated secondary antibodies and diluted 1:600 in Dako antibody diluent (#S3022) for 1 h at RT. Images were captured using an Olympus IX71 fluorescence microscope and the Slidebook version 4.0 software.
###end p 70
###begin p 71
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
Samples from human muscular disorders were obtained under IRB approval at the corresponding collaborating institutes in Italy and Japan. For the human sample processing, immunohistochemistry was performed on unfixed cryostat sections of diagnostic muscle biopsies from patients with the following diagnosis: s-IBM (10), DMD (2), BMD (2), normal muscle (3). After blocking, sections were incubated overnight at 4degrees with RNF5 antibody (1:100) and either monoclonal anti-phosphorylated tau SMI31 (1:5000, (Sternberger Monoclonals, Baltimore, MD, USA) or anti-beta amyloid protein (1:100, Biosource International, Camarillo, CA, USA, clone 6E10). Sections were incubated for 1 hr at RT with the appropriate Alexa fluor-conjugated secondary antibodies and Hoechst 33258 (Molecular Probes Inc.) staining was used to visualize cell nuclei. Slides were analyzed under a laser scanning confocal microscope SP5 (Leica, Germany)
###end p 71
###begin title 72
Phenotypic analysis of double transgenic and control animals
###end title 72
###begin p 73
A 2 mg/ml solution of doxycyclin supplemented with 5% sucrose was given to littermates animals between 12 wk and 24 wk of age in drinking water for 6 wk. Phenotypic alteration (body mass, weakness, blood withdrawal) were observed bi-weekly and the animals were sacrificed after 6 wk of treatment. Organs were individually weighed on a precision sale after trimming of the extra-tissues. Organs were then flash frozen in liquid nitrogen for expression analysis and frozen in OTC for immunohistochemical analysis.
###end p 73
###begin title 74
Electron Microscopy
###end title 74
###begin p 75
Glutaraldehyde-fixed muscle specimens were post-fixed in osmium tetroxide, and dehydrated in serial alcohol solutions and propylene oxide prior to embedding in araldite resin. Thick sections (1 microm) were stained with toluidine blue for light microscopy and ultrathin (60 nm) sections stained with uranyl acetate and lead citrate for electron microscopy.
###end p 75
###begin title 76
Morphometric analysis of skeletal muscle cross-sections
###end title 76
###begin p 77
Cross-sections of the triceps brachii, tibialis anterior, and vastus lateralis muscles from the double transgenic animals and their matching controls were immunostained with dystrophin and H&E to delineate the fibers, and the cross-section area of each fiber was quantified using Scion software (version 4.0.3.2; NIH).
###end p 77
###begin title 78
Evans Blue Dye Injection
###end title 78
###begin p 79
###xml 213 217 <span type="species:ncbi:10090">mice</span>
Evans Blue Dye (SIGMA) was diluted in PBS (10mg/ml) and filter-sterilized and the dye was injected through the tail vein at a concentration of 100microl per gram of body weight. Sixteen hours after injection, the mice were sacrificed and dissected muscles inspected for presence of blue dye in the muscle. Skeletal muscles were then fresh-frozen and cross-sections were further analyzed for presence of dye and counter-stained with dystrophin antibody as described above.
###end p 79
###begin title 80
Serum Creatine Kinase Assay
###end title 80
###begin p 81
150 microl of blood was collected in heparin-treated tubes from periorbital bleeding and the serum fraction extracted by double centrifugation for 5 min at 5000 rpm. Creatine kinase levels were monitored using CPK-NAC kit (JAS Diagnostics #CPK1-15) and analyzed on a Roche Cobas Mira classic apparatus.
###end p 81
###begin title 82
Isolation of primary myoblast from muscle fibers
###end title 82
###begin p 83
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5 STg</italic>
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rtTA RNF5 DTg</italic>
###xml 587 592 <span type="species:ncbi:9796">horse</span>
###xml 814 819 <span type="species:ncbi:9796">horse</span>
###xml 936 941 <span type="species:ncbi:9796">horse</span>
###xml 954 959 <span type="species:ncbi:9031">chick</span>
###xml 1060 1065 <span type="species:ncbi:9796">horse</span>
###xml 1082 1087 <span type="species:ncbi:9031">chick</span>
One month old animals (RNF5 STg and rtTA RNF5 DTg) were sacrificed and tibialis anterior, gastrocnemius and soleus muscles were collected and rinsed in sterile PBS. Muscles were then digested in sterile filtered type 1 collagenase (0.2%) in DMEM using a shaking water bath for 2 hours at 37 degrees. Muscle fibers were then extracted by trituration after dilution of the digestion medium in one volume of DMEM. Single muscle fibers were then separated from debris by gently aspirating the fibers under a dissecting microscope and transferring them in a new dish containing DMEM plus 10% horse serum. This step was repeated 3 or 4 times in a row to separate intact fibers from the debris. 20 to 30 fibers were then plated in 60 mm dishes coated with 10% Matrigel and were incubated for 12-24 hours in DMEM plus 10% horse serum. Satellite cells were then allowed to proliferate for 3 days by changing the medium to DMEM plus 20% FBS, 10% horse serum, 0,5% chick embryo extract. Differentiation of myoblasts was subsequently achieved by changing the medium to 2% horse serum plus 0.5% chick embryo extract in DMEM. Doxycyclin (2 microg/ml) was added to the proliferation medium and the differentiation media to promote and maintain the expression of RNF5 transgene before and during the differentiation process.
###end p 83
###begin title 84
Immunocytochemistry
###end title 84
###begin p 85
###xml 325 331 <span type="species:ncbi:9913">bovine</span>
###xml 572 578 <span type="species:ncbi:9986">rabbit</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
Cells were washed in PBS and fixed using freshly prepared 3% paraformaldehyde in PBS (10 min at room temperature). The cells were then washed in PBS, followed by permeabilization in 0.1% Triton X-100 in PBS (pH 7.4) for 5min on ice and an additional three washes in PBS. Cells were then incubated in PBS supplemented with 3% bovine serum albumin for 30 min. The cells were incubated with antibodies (1 h at room temperature) in a humidity chamber. The cells were washed in PBS (3x, 5 min each) before incubation with 100-microl of Alexa-488- and Alexa-568-conjugated anti-rabbit or anti-mouse immunoglobulin G (Molecular Probes) diluted (2 microg/ml) in PBS containing 3% BSA (60 min at room temperature in a light protected humidity chamber). The cells were rinsed three times in PBS and mounted on glass slides using Vectashield (Vector Laboratories). Primary antibodies were used as follows: RNF5 (1:200), sarcomeric alpha-actinin (Sigma, 1:5000), Pax7 (Hybridoma Bank, 1:10).
###end p 85
###begin title 86
Generation of RNF5 KO animals
###end title 86
###begin p 87
###xml 610 641 606 637 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCAGCTGAAGGTGAGGGACTGGAC-3&#8242;</named-content>
###xml 651 684 647 680 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCGAGGCCAGAGGCCACTTGTGTAGC-3&#8242;</named-content>
###xml 1394 1421 1390 1417 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCCTATGTCCTACAGGCTCTG-3&#8242;</named-content>
###xml 1433 1463 1429 1459 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACACGATGCTGAGGGGAGCTGCAG-3&#8242;</named-content>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 883 887 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1204 1208 <span type="species:ncbi:10090">mice</span>
RNF5 targeting vector consisted of a 9kb 5' homologous region and 1.5 kb 3' homologous region of RNF5 genomic sequence which was inserted into 5' of Neo gene cassette using PspOMI site. The Neo gene cassette was inserted to replace exon 1, 2 and 3 including the first ATG. Linearized targeting vector (10 microg) was transfected by electroporation into 129SvEv ES cells and screened for G418-resistant clones. Surviving colonies were expanded and PCR analysis was performed to identify clones that had undergone homologous recombination. Homologous recombination was confirmed by PCR using primer pairs, ZESA6 5'-GCCAGCTGAAGGTGAGGGACTGGAC-3' and Neo1 5'-TGCGAGGCCAGAGGCCACTTGTGTAGC-3' The correctly targeted ES cell lines were microinjected into C57BL/6J blastocytes. The chimeric mice were generated and selected for a germline transmission of the disrupted RNF5 gene. Heterozygous mice were interbred to produce litters that included homozygous offspring. Additional analysis was carried out using DNA prepared from the MEFs that were obtained from these mice, further confirming the deletion of RNF5 gene. Chimeric mice with germline transmission were mated with C57BL/6J. The targeting vector and KO mice were generated by ITL, (Long Island NY). Backcross to C57BL/6J allowed to generate >90% strain. Genotyping were carried out by Southern blotting or PCR. Primers used for PCR were ZESA2 5'-CCCTATGTCCTACAGGCTCTG-3' and ZESA20 5'-ACACGATGCTGAGGGGAGCTGCAG-3' for the wild type allele, and ZESA6 and Neo1 for the targeted allele.
###end p 87
###begin title 88
Cardiotoxin treatment
###end title 88
###begin p 89
Four-month-old wild-type and RNF5 null animals were anaesthetized with isoflurane, and 100 microl of 10 microM cardiotoxin (CalBiochem) in 1xPBS was injected into the right tibialis muscle. The animals were sacrificed at 3, 4, 6, 12 and 28 days after cardiotoxin injection. Tibialis muscles were harvested tendon-to-tendon and mounted in OCT or flash frozen in liquid nitrogen for histological or protein analysis.
###end p 89
###begin title 90
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
RNF5 silencing by siRNA
###end title 90
###begin p 91
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF5</italic>
###xml 191 260 191 260 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GATCCCCAGCTGGGATCAGCAGAGAGttcaagagaCTCTCTGCTGATCCCAGCT TTTTTGGAAA3&#8242;</named-content>
###xml 265 335 265 335 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AGCTTTTCCAAAAAAGCTGGGATCAGCAG AGAGTCTCTTGAACTCTCTGCTGATCCCAGCTGGG-3&#8242;</named-content>
###xml 425 455 425 455 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCCCC AGCTGGCATCAGCAGGGAG</named-content>
###xml 466 499 466 499 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCCCTGCTGATGCCAGCT TTTTTGGAAA 3&#8242;</named-content>
###xml 504 574 504 574 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AGCTTTTCCAAAAAAGCTGGCATCAGCAGGGA GTCTCTTGAACTCCCTGCTGATGCCAGCTGGG 3&#8242;</named-content>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001609-Gomez1">[46]</xref>
The pCMS3-cherry vector was used to transfect short interfering RNA (siRNA) targeting RNF5 and its corresponding scramble control into Hela cells. Two 64-base complementary oligonucleotides (5'GATCCCCAGCTGGGATCAGCAGAGAGttcaagagaCTCTCTGCTGATCCCAGCT TTTTTGGAAA3' and 5'AGCTTTTCCAAAAAAGCTGGGATCAGCAG AGAGTCTCTTGAACTCTCTGCTGATCCCAGCTGGG-3') were synthesized to contain a RNF5 19-nucleotide sequence or its scramble counterpart ( 5'-GATCCCC AGCTGGCATCAGCAGGGAG ttcaagaga CTCCCTGCTGATGCCAGCT TTTTTGGAAA 3' and 5'AGCTTTTCCAAAAAAGCTGGCATCAGCAGGGA GTCTCTTGAACTCCCTGCTGATGCCAGCTGGG 3'). The annealed product containing 5' and 3' overhangs compatible with BglII and HindIII restriction sites, respectively was then ligated into pCMS3-cherry digested with BglII and HindIII [46].
###end p 91
###begin title 92
Supporting Information
###end title 92
###begin p 93
###xml 517 523 <span type="species:ncbi:9986">rabbit</span>
Specificity of RNF5 antibody. A. Specificity of RNF5 staining in cells where RNF5 expression has been downregulated by specific shRNA. HeLa cells were transfected with a plasmid expressing both the Cherry fluorescent marker and RNF5-specific shRNA or its scrambled version and analyzed for RNF5 expression by immunocytochemistry after 36 hours. B. Specificity of RNF5 antibody on muscle cross-sections. Triceps brachii cross-sections from RNF5 DTg or STg were stained with RNF5 antibody or a similar concentration of rabbit IgG. Arrowheads point areas of RNF5 staining.
###end p 93
###begin p 94
(2.89 MB TIF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
RNF5 expression in human myopathies. RNF5 immunostaining of muscle sections from Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) patients compared to a normal muscle cross-section. Arrowheads point to RNF5 staining.
###end p 96
###begin p 97
(4.86 MB TIF)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
###xml 158 162 <span type="species:ncbi:10090">mice</span>
RNF5 overexpression is not associated with alterations in the dystrophin-glycoprotein complex. Cross-sections of vastus lateralis from treated DTg or control mice were subjected to immunostaining using dystrophin (A) laminin alpha3 (B) and alpha-dystroglycan (C), revealing a normal pattern of sarcolemmal and extracellular matrix staining.
###end p 99
###begin p 100
(4.51 MB TIF)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
RNF5 overexpression does not prevent proper differentiation and sarcomeric organization of primary myoblasts. Primary myoblasts were isolated from 1 month old animals (RNF5 STg and rtTA RNF5 DTg) and grown in the presence of doxycyclin (2 microg/ml). Differentiation was achieved by switching cells to differentiation medium supplemented with ITS (Insulin Transferrin Selenium supplement). Induction of RNF5 in primary myoblasts prior to differentiation was confirmed by co-immunostaining with Pax7 (A) and the efficiency of myoblast differentiation was monitored by analysis of phase contrast images (bottom panels) and immunostaining the sarcomeres with sarcomeric alpha-actinin (upper panels) (B).
###end p 102
###begin p 103
(9.47 MB TIF)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
GRP94 expression in muscles of cardiotoxin-treated RNF5 KO and WT animals. Proteins prepared from muscle of RNF5 KO or WT animals were quantified and analyzed by western blot analysis using antibodies to GRP94. Upper band correspond to a post translationally modified form of GRP94.
###end p 105
###begin p 106
(0.45 MB TIF)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
The authors thank Norma Huff for great technical support on muscle preparation, Chiara Mozzetta and Sonia Forcales for help on muscle fiber isolation and valuable advice and Daniel Billadeau for providing us with shRNA expression vectors and Dr Nina Raben for providing us with MCK-tTA mouse strain. We also thank Dr Valerie Askanas and members of the Ronai lab for helpful discussion.
###end p 108
###begin title 109
References
###end title 109
###begin article-title 110
Atrophy and hypertrophy of skeletal muscles: structural and functional aspects.
###end article-title 110
###begin article-title 111
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
###end article-title 111
###begin article-title 112
Biology of cachexia.
###end article-title 112
###begin article-title 113
The molecular basis of skeletal muscle atrophy.
###end article-title 113
###begin article-title 114
Response of the ubiquitin-proteasome pathway to changes in muscle activity.
###end article-title 114
###begin article-title 115
Identification of ubiquitin ligases required for skeletal muscle atrophy.
###end article-title 115
###begin article-title 116
MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination.
###end article-title 116
###begin article-title 117
The E3 Ligase MuRF1 Degrades Myosin Heavy Chain Protein in Dexamethasone-Treated Skeletal Muscle.
###end article-title 117
###begin article-title 118
Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction.
###end article-title 118
###begin article-title 119
A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy.
###end article-title 119
###begin article-title 120
Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis.
###end article-title 120
###begin article-title 121
Muscle-specific RING finger-2 (MURF-2) is important for microtubule, intermediate filament and sarcomeric M-line maintenance in striated muscle development.
###end article-title 121
###begin article-title 122
Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.
###end article-title 122
###begin article-title 123
Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H.
###end article-title 123
###begin article-title 124
Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.
###end article-title 124
###begin article-title 125
Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
###end article-title 125
###begin article-title 126
Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle.
###end article-title 126
###begin article-title 127
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 122 144 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Cloning, expression and mapping of a novel RING-finger gene (RNF5), a human homologue of a putative zinc-finger gene from Caenorhabditis elegans.
###end article-title 127
###begin article-title 128
###xml 57 68 <span type="species:ncbi:3702">Arabidopsis</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Rma1, a novel type of RING finger protein conserved from Arabidopsis to human, is a membrane-bound ubiquitin ligase.
###end article-title 128
###begin article-title 129
###xml 144 154 <span type="species:ncbi:6239">C. elegans</span>
The LIM domain protein UNC-95 is required for the assembly of muscle attachment structures and is regulated by the RING finger protein RNF-5 in C. elegans.
###end article-title 129
###begin article-title 130
Mutants altering coordinate synthesis of specific myosins during nematode muscle development.
###end article-title 130
###begin article-title 131
RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization.
###end article-title 131
###begin article-title 132
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.
###end article-title 132
###begin article-title 133
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
###end article-title 133
###begin article-title 134
Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo.
###end article-title 134
###begin article-title 135
Cellular and molecular regulation of muscle regeneration.
###end article-title 135
###begin article-title 136
Endoplasmic reticulum stress: cell life and death decisions.
###end article-title 136
###begin article-title 137
Orchestrating the unfolded protein response in health and disease.
###end article-title 137
###begin article-title 138
Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development.
###end article-title 138
###begin article-title 139
Cell stress response in skeletal muscle myofibers.
###end article-title 139
###begin article-title 140
Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence.
###end article-title 140
###begin article-title 141
Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor.
###end article-title 141
###begin article-title 142
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat.
###end article-title 142
###begin article-title 143
Identification of genes related to Parkinson's disease using expressed sequence tags.
###end article-title 143
###begin article-title 144
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.
###end article-title 144
###begin article-title 145
###xml 70 75 <span type="species:ncbi:9606">human</span>
The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy.
###end article-title 145
###begin article-title 146
###xml 79 101 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
The UNC-45 chaperone mediates sarcomere assembly through myosin degradation in Caenorhabditis elegans.
###end article-title 146
###begin article-title 147
Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction.
###end article-title 147
###begin article-title 148
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies.
###end article-title 148
###begin article-title 149
XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks.
###end article-title 149
###begin article-title 150
An initial blueprint for myogenic differentiation.
###end article-title 150
###begin article-title 151
Endoplasmic reticulum stress increases myofiber formation in vitro.
###end article-title 151
###begin article-title 152
Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility.
###end article-title 152
###begin article-title 153
Polyubiquitination of p53 by a ubiquitin ligase activity of p300.
###end article-title 153
###begin article-title 154
Muscle biopsy: A practical approach; Ed B-TWBSn, editor. London, Toronto.
###end article-title 154
###begin article-title 155
Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse.
###end article-title 155
###begin p 156
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 156
###begin p 157
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Support by NCI (CA097105 to ZR) is gratefully acknowledged.
###end p 157

